[0R2M] YoY Annual Result on 31-Dec-2022 [#FY]

Stock
[0R2M] Regeneron Pharmaceuticals, Inc.
Announcement Date
06-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#FY]
Profit Trend
YoY- -46.28%
Quarter Report
0R2M's Result
0R2M's Financial Summary
View:
Show?
Annual Result
31/12/25 31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
Revenue 14,342,900 14,202,000 13,117,200 12,172,900 16,071,700 8,497,100 6,557,600 13.91%
PBT 5,230,700 4,779,900 4,199,300 4,858,800 9,325,800 3,810,400 2,429,100 13.62%
Tax 725,800 367,300 245,700 520,400 1,250,500 297,200 313,300 15.01%
NP 4,504,900 4,412,600 3,953,600 4,338,400 8,075,300 3,513,200 2,115,800 13.41%
Tax Rate -13.88% -7.68% -5.85% -10.71% -13.41% -7.80% -12.90% -
Total Cost 9,838,000 9,789,400 9,163,600 7,834,500 7,996,400 4,983,900 4,441,800 14.15%
Ratio Analysis
31/12/25 31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
NP Margin 31.41 31.07 30.14 35.64 50.25 41.35 32.26 -0.44%
Per Share
31/12/25 31/12/24 31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
EPS 43.07 40.90 37.05 40.51 76.40 32.65 19.38 14.22%
EPS Diluted 41.48 38.34 34.77 38.22 71.97 30.52 18.46 14.43%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.